Medmix AGMDMXF 61 EPS without NRI is $0.24 as of Dec. 2025. GuruFocus rates MDMXF with a GF Score™ of 61/100 and a GF Value™ of $26.13. The stock has 7 warning signs investors should review. Among 2,419 Industrial Products companies, Medmix AG ranks worse than 91.07% on this metric.
Medmix AG's earnings per share without non-recurring items for the
six
months ended in Dec. 2025 was $0.16.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $0.24.
During the past 12 months, Medmix AG's average earnings per share (NRI) Growth Rate was 108.60% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -41.20% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Medmix AG's EPS without NRI or its related term are showing as below:
MDMXF'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -57.6 Med: -24.8 Max: -2.9
Current: -41.2
During the past 8 years, Medmix AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -2.90% per year. The lowest was -57.60% per year. And the median was -24.80% per year.
MDMXF's 3-Year EPS without NRI Growth Rate is ranked worse than 91.07% of 2419
companies
in the Industrial Products industry
Industry Median: 3.5
vs MDMXF: -41.20
Medmix AG's EPS (Diluted) for the
six
months ended in Dec. 2025 was $-0.01.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.18.
Medmix AG's EPS (Basic) for the
six
months ended in Dec. 2025 was $-0.01.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.20.
Medmix AG (OTCPK:MDMXF) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Medmix AG EPS without NRI Related Terms
Medmix AG EPS without NRI Historical Data
* Premium members only.
The historical data trend for Medmix AG's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Medmix AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG PE Ratio without NRI vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Medmix AG's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (MDMXF) has a EPS without NRI of $0.24 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Medmix AG and its competitors. According to the industry distribution chart, Medmix AG ranks #2203 out of 2419 companies in the Industrial Products industry, placing it in the top 91.1%.
Is Medmix AG's EPS without NRI too high?
Medmix AG's current EPS without NRI is $0.24. The Industrial Products industry median EPS without NRI is 3.50. Medmix AG's value of $0.24 is 93.1% below this industry median. Based on the distribution chart, Medmix AG ranks #2203 out of 2419 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Medmix AG has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's EPS without NRI compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #2203 out of 2419 companies for EPS without NRI. This places Medmix AG in the lower half of its industry. The industry median EPS without NRI is 3.50. Medmix AG's value of $0.24 is 93.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Industrial Products company?
The median EPS without NRI among Industrial Products companies is 3.50, based on 2,419 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current EPS without NRI of $0.24 is 93.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median EPS without NRI is 3.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current EPS without NRI is $0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current EPS without NRI of $0.24. The stock's GF Value™ is $26.13, compared to a current price of $17.40 — trading 33.4% below its estimated fair value. The current EPS without NRI is $0.24 and 93.1% below the Industrial Products industry median of 3.50. Medmix AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Medmix AG (MDMXF), the current EPS without NRI is $0.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (MDMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.
Key valuation signals for MDMXF:
EPS without NRI: $0.24
GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
Industry Position: 93.1% below the Industrial Products median (#2203 of 2419)
No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score
Get the complete analysis for MDMXF
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDMXF has been successfully added to your 
